```html

Irradiation‑Induced Skin Reaction

Overview

Irradiation‑induced skin reaction (also called radiation dermatitis, radiodermatitis, or radiation‑induced skin toxicity) is a common side‑effect of therapeutic ionising radiation used to treat cancer. The skin in the radiation field becomes inflamed, irritated, or damaged because radiation damages the DNA of skin cells and the surrounding micro‑vasculature.

• Who it affects: Anyone receiving external beam radiotherapy (EBRT) or brachytherapy for malignancies such as breast, head & neck, prostate, gastrointestinal, or skin cancers.
• Prevalence: Up to 90‑95 % of patients develop some degree of skin change during or shortly after treatment; 30‑40 % experience moderate to severe reactions (grade 2‑3) that interfere with daily activities.<sup>1</sup>
• Typical timeline: Acute reactions appear within 1‑4 weeks of starting radiation and peak 1‑2 weeks after treatment ends. Chronic changes can persist months to years later.

Symptoms

Symptoms vary by severity (graded 0‑4 by the Common Terminology Criteria for Adverse Events, CTCAE). Below is a complete list with plain‑language descriptions.

Grade 0 (No visible reaction)

• Normal skin appearance.

Grade 1 (Mild)

• Redness (erythema) similar to a mild sunburn.
• Slight warmth or itching.
• No skin breakdown.

Grade 2 (Moderate)

• Bright red, dry or moist skin that may feel tender.
• Peeling or flaking (dry desquamation).
• Swelling (edema) of the treated area.
• Discomfort that may limit clothing choice or daily activities.

Grade 3 (Severe)

• Moist desquamation – areas where the outer skin layer has broken down, leaving a wet, yellow‑white film.
• Open ulcerations or blistering.
• Significant pain, burning, or pruritus.
• Possible bleeding or serous (clear) drainage.

Grade 4 (Life‑threatening)

• Full‑thickness skin necrosis.
• Deep ulceration that may expose underlying tissue or bone.
• Severe infection or gangrene.

Other possible sensations

• Stinging or pins‑and‑needles (paresthesia) if nerves are irritated.
• Increased sensitivity to heat or friction.
• Hyperpigmentation (darkening) or hypopigmentation (lightening) that can persist after healing.

Causes and Risk Factors

Primary cause

Ionising radiation damages rapidly dividing basal keratinocytes and dermal fibroblasts, leading to inflammation, loss of barrier function, and impaired wound healing.

Key risk factors

• Radiation dose & fractionation: Higher total dose (>50 Gy) or larger dose per fraction increases risk.
• Treatment field size: Larger fields expose more skin surface.
• Concurrent chemotherapy or targeted agents: Drugs such as 5‑fluorouracil, taxanes, EGFR inhibitors, and immunotherapy potentiate skin toxicity.<sup>2</sup>
• Patient‑related factors:
  • Skin type – Fair skin (Fitzpatrick I‑II) is more prone to erythema.
  • Age – Elderly patients have thinner epidermis and reduced regenerative capacity.
  • Smoking – Impairs micro‑circulation.
  • Diabetes, vascular disease, or malnutrition – Delay healing.
• Anatomical location: Areas with skin folds (axilla, inframammary region) or bony prominences are more vulnerable.
• Previous radiation: Re‑irradiation compounds toxicity.

Diagnosis

Diagnosis is primarily clinical, based on visual assessment and patient‑reported symptoms. No laboratory test is required in most cases, but certain investigations help rule out infection or other causes.

Clinical evaluation

• Physical exam of the irradiated field – assess color, texture, presence of desquamation, ulceration.
• Grading using CTCAE or RTOG (Radiation Therapy Oncology Group) scales.

Ancillary tests (when indicated)

• Swab culture: If ulceration is present and there is drainage, to detect bacterial infection.
• Biopsy: Rarely needed, used when cancer recurrence, radiation‑induced sarcoma, or atypical dermatitis is suspected.
• Imaging (ultrasound or MRI): If deep tissue involvement or osteoradionecrosis is a concern.

Treatment Options

General principles

• Prevent progression from dry to moist desquamation.
• Maintain a moist, clean wound environment.
• Control pain and itching.
• Address any secondary infection promptly.

Topical agents

• Barrier creams/ointments: Zinc oxide, petrolatum, or silicone‑based dressings protect intact skin (grade 0‑1).
• Moisturizers: Fragrance‑free emollients applied 2‑3 times daily.
• Medicated creams for grade 2‑3:
  • Topical corticosteroids (e.g., 1 % clobetasol ointment) reduce inflammation.
  • Mupirocin or bacitracin for localized bacterial colonisation.
  • Silver‑impregnated dressings for moist desquamation.

Systemic medication

• Analgesics: Acetaminophen or NSAIDs for mild pain; short courses of opioids for severe pain under physician supervision.
• Oral antihistamines: Diphenhydramine or cetirizine for pruritus.
• Systemic steroids: Rarely used, only for extensive inflammatory reactions.

Advanced wound‑care modalities

• Hydrocolloid or hydrogel dressings to maintain a moist environment.
• Negative‑pressure wound therapy (NPWT) in selected grade 3‑4 cases.
• Hyperbaric oxygen therapy for chronic, non‑healing radiation ulcers (off‑label, evidence limited).

Physical and supportive measures

• Cool compresses: 10‑15 minutes, 3–4 times daily for erythema.
• Gentle cleansing: Mild, fragrance‑free soap with lukewarm water; pat dry.
• Clothing: Loose, breathable fabrics; avoid tight bands that friction the area.

Living with Irradiation‑Induced Skin Reaction

Daily skin‑care routine

1. Clean the area with a soft cloth and mild soap; rinse thoroughly.
2. Apply a thin layer of a prescribed barrier cream or moisturizer while the skin is still slightly damp.
3. Change dressings (if any) according to the wound‑care nurse’s instructions—usually every 24‑48 hours.
4. Avoid scratching; use a cool, damp cloth to relieve itching.

Activity and lifestyle tips

• Limit sun exposure – use broad‑spectrum sunscreen (SPF 30‑50) on non‑irradiated surrounding skin.
• Stay hydrated – 2–3 L of water per day supports skin regeneration.
• Maintain a balanced diet rich in protein, vitamin C, zinc, and vitamin E (e.g., lean meats, citrus fruit, nuts, leafy greens).
• Quit smoking; nicotine impedes vascular flow.
• Report any new drainage, foul odor, or increasing pain to your oncology team promptly.

Psychosocial considerations

Visible skin changes can affect body image and emotional well‑being. Seek support from counseling services, patient support groups, or a mental‑health professional if distress persists.

Prevention

• Pre‑treatment skin assessment: Identify pre‑existing dermatitis, eczema, or infection.
• Optimise radiation planning: Modern techniques (IMRT, VMAT, proton therapy) spare more normal tissue.
• Prophylactic moisturisation: Begin gentle moisturiser 1–2 weeks before radiotherapy start and continue throughout.
• Avoid irritants: No harsh soaps, alcohol‑based wipes, or scented lotions on the treatment field.
• Educate on clothing: Wear cotton undergarments and avoid belts, bras, or straps that compress the irradiated area.
• Manage concurrent therapies: Coordinate chemotherapy schedules; dose reductions may be considered if severe skin toxicity develops.
• Smoking cessation programs: Offer nicotine replacement or counseling.

Complications

If a radiation dermatitis is not appropriately managed, several complications can arise:

• Infection: Bacterial colonisation leading to cellulitis or sepsis.
• Chronic ulceration: Non‑healing wounds that may require surgical debridement or flap reconstruction.
• Fibrosis & contracture: Excess scar tissue restricting movement, especially problematic over joints (e.g., neck, axilla).
• Delayed radiation therapy: Severe skin toxicity can force interruption or dose reduction, potentially compromising cancer control.
• Radiation‑induced secondary malignancy: Chronic ulcerated lesions have a very low but recognized risk of transformation.

When to Seek Emergency Care

---

References:
1. American Cancer Society. “Radiation Therapy Side Effects.” 2023.
2. Jagsi R, et al. “Concurrent Chemoradiation and Skin Toxicity.” J Clin Oncol. 2022;40(12):1435‑1444.
3. Mayo Clinic. “Radiation dermatitis.” Accessed May 2024.
4. NCI. “Radiation Therapy Side Effects.” National Cancer Institute, 2023.
5. American Society for Radiation Oncology (ASTRO). “Management of Acute Radiation Dermatitis.” 2021.

```